Paul Wang to Cross-Over Studies
This is a "connection" page, showing publications Paul Wang has written about Cross-Over Studies.
Connection Strength
0.033
-
Arbaclofen in Children and Adolescents with Autism Spectrum Disorder: A Randomized, Controlled, Phase 2 Trial. Neuropsychopharmacology. 2017 Jun; 42(7):1390-1398.
Score: 0.033